RYREX
Price
$43.15
Change
-$0.18 (-0.42%)
Updated
Sep 20 closing price
VGSNX
Price
$21.46
Change
-$0.07 (-0.33%)
Updated
Sep 20 closing price
Ad is loading...

RYREX vs VGSNX

Header iconRYREX vs VGSNX Comparison
Open Charts RYREX vs VGSNXBanner chart's image
Rydex Real Estate A
Price$43.15
Change-$0.18 (-0.42%)
VolumeN/A
CapitalizationN/A
Vanguard Real Estate Index Institutional
Price$21.46
Change-$0.07 (-0.33%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
RYREX vs VGSNX Comparison Chart
Loading...
VS
RYREX vs. VGSNX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYREX is a StrongSell and VGSNX is a StrongSell.

FUNDAMENTALS
Fundamentals
VGSNX has more cash in the bank: 70.5B vs. RYREX (7.86M). VGSNX pays higher dividends than RYREX: VGSNX (4.01) vs RYREX (1.94). RYREX was incepted earlier than VGSNX: RYREX (20 years) vs VGSNX (21 years). RYREX is a more actively managed with annual turnover of: 308.00 vs. VGSNX (9.00). RYREX has a lower initial minimum investment than VGSNX: RYREX (2500) vs VGSNX (5000000). VGSNX (30.91) and RYREX (30.70) have marching annual gain over last year. VGSNX return over 5 years is better than : 26.49 vs. RYREX (17.56).
RYREXVGSNXRYREX / VGSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years21 years-
Gain YTD13.67213.136104%
Front LoadN/AN/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets7.86M70.5B0%
Annual Yield % from dividends1.944.0148%
Returns for 1 year30.7030.9199%
Returns for 3 years-0.163.89-4%
Returns for 5 years17.5626.4966%
Returns for 10 years64.0289.8671%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APGE58.385.43
+10.25%
Apogee Therapeutics
AEI1.230.02
+1.28%
Alset
VTOL36.00-0.43
-1.18%
Bristow Group
TRMB58.58-1.62
-2.69%
Trimble
LFCR5.00-0.62
-11.03%
Lifecore Biomedical